Navigation Links
Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery
Date:8/26/2008

SEATTLE, Aug. 26 /PRNewswire/ -- Omeros Corporation today announced the publication of the results from a Phase 1/Phase 2 trial investigating OMS103HP in arthroscopic anterior cruciate ligament (ACL) reconstruction surgery. OMS103HP is an investigational drug product that is added to arthroscopic irrigation solution and is designed to improve postoperative knee function and motion, reduce postoperative pain and allow patients an earlier return to work. The article titled "Novel Drug Product to Improve Joint Motion and Function and Reduce Pain After Arthroscopic Anterior Cruciate Ligament Reconstruction" appeared in the June 2008 edition of Arthroscopy: The Journal of Arthroscopic and Related Surgery.

The article reports on a prospective, double-blind, vehicle-controlled study of 30 evaluable patients undergoing arthroscopic allograft ACL reconstruction. Patients were randomized across two arms to receive either standard arthroscopic irrigation solution or the same solution with OMS103HP added to it. Patients were monitored for safety, and efficacy endpoints assessed over the 30-day postoperative period included measurements of knee function and motion, leg muscle strength, pain and return to work.

Results of the study demonstrated a statistically significant improvement in knee function, range of motion, quadriceps and hamstring muscle strength, pain management and return to work in OMS103HP-treated patients. The incidence of adverse events and abnormal clinical laboratory values for OMS103HP and the control arm were similar.

"We are pleased that Arthroscopy, a well-respected and peer-reviewed journal, chose to publish these clinical results obtained using OMS103HP, the most clinically advanced of our PharmacoSurgery product candidates," said Gregory A. Demopulos, M.D., Chairman and CEO of Omeros. "We look forward to completing our ongoing Phase 3 clinical program further evaluating the safety and efficacy of OMS103HP."

OMS103HP is
'/>"/>

SOURCE Omeros Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Omeros Announces Initiation of Patient Enrollment in OMS201 Phase 1 Study
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... 2014 /PRNewswire-iReach/ -- Dr. Michael Gabriel of a ... to a recent study, which shows how grief in pregnancy ... http://photos.prnewswire.com/prnh/20140723/129709 According to US News ... more likely than others to grow up overweight or obese, ... There were two specific types of stress that caused obesity: ...
(Date:7/24/2014)... , July 24, 2014  Restore Health, ... and compounded pharmaceuticals, announced that it is now ... unique to each individual based upon their particular ... by understanding the interaction between a patient,s genetics ... "We,re very excited to provide this new service ...
(Date:7/24/2014)... Inc. (NasdaqGS: ABAX ), a medical products ... results for the first fiscal quarter ended June 30, ... of $47.5 million, up 10% over last year,s comparable ... over last year,s comparable quarter. Revenues highlights: ... 20% over last year,s comparable quarter. , Veterinary ...
Breaking Medicine Technology:Dr. Michael Gabriel of GPM Pediatrics, a Noted Staten Island Pediatrics Clinic, Comments on Study, Which Names Grief as a Cause of Obesity in Children 2Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 2Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 2Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 4Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 6Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 7Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 8Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 9Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 10Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 11
... a constant reality across the country, from New York to ... companies might be forgiven for not placing the environment high ... Durable Medical Equipment in the Southwestern United States, has an ... to remain in the black is to go green. ...
... Systems, Inc. (Nasdaq:  SPAN) will provide an online, real-time ... January 27, 2011, covering results for the first quarter ... close of trading the preceding day. The ... online at www.spanamerica.com under investor relations on ...
Cached Medicine Technology:Maldonado Medical's Green Initiative, a Model for the American Small Business 2
(Date:7/25/2014)... July 25, 2014 CMS recently has ... plans for providing inadequate access to prescription drugs. Agency ... the health and safety of beneficiaries in areas such ... determinations, and CMS is taking quick and firm actions ... Information Services webinar, “Avoiding Costly Part D Sanctions: ...
(Date:7/25/2014)... Fort Myers, FL (PRWEB) July 25, 2014 ... Apple iPhones, iPods, and iPads. The app provides a ... preventing painful and potentially dangerous sunburns and skin damage. ... about the sights, sounds, and capabilities of iTanSmart. ... by describing the app as a ‘better organized’ and ...
(Date:7/25/2014)... 2014 As the category creator and world ... is to transform and improve individual lives worldwide through ... Paul Green a successful Austin, Texas based "Xocai Activ ... end of the July to promote the up and coming ... , Eric Worre has been a leader in the Network ...
(Date:7/24/2014)... (PRWEB) July 25, 2014 iFitDress.com, a ... its new range of casual party dresses . ... casual party gowns are now offered at discounted prices, ... from this morning until August 04. , Most ... popular in the global market. They are popular for ...
(Date:7/24/2014)... For rats bearing human breast tumors, exposure to ... the breast cancer drug tamoxifen, according to data published ... American Association for Cancer Research. The negative effects of ... giving rats a melatonin supplement during the night. , ... with hormone receptor-positive breast cancer," said Steven M. Hill, ...
Breaking Medicine News(10 mins):Health News:Aug. 5 Webinar to Offer Strategies for Preventing Rx Access Issues and Avoiding Part D Sanctions 2Health News:iTanSmart® Suntan App by UV Technologies, LLC Gets a ‘Big Thumbs Up’ from New York Times App Smart Columnist, Kit Eaton 2Health News:iTanSmart® Suntan App by UV Technologies, LLC Gets a ‘Big Thumbs Up’ from New York Times App Smart Columnist, Kit Eaton 3Health News:Austin, Texas Based "Xocai Activ Drink" Author, Adam Paul Green, to Visit Niigata Japan to Promote mxicorp.com/company/igc Eric Worre Speaking Engagement 2Health News:Austin, Texas Based "Xocai Activ Drink" Author, Adam Paul Green, to Visit Niigata Japan to Promote mxicorp.com/company/igc Eric Worre Speaking Engagement 3Health News:Austin, Texas Based "Xocai Activ Drink" Author, Adam Paul Green, to Visit Niigata Japan to Promote mxicorp.com/company/igc Eric Worre Speaking Engagement 4Health News:2014 Casual Party Dresses for Chic Ladies Now at iFitDress.com 2Health News:Exposure to dim light at night may make breast cancers resistant to tamoxifen 2
... almost 4,000 centers , , THURSDAY, May 22 (HealthDay ... on the quality of care in American hospitals was ... and Human Services. , The ads, which began appearing ... department,s Hospital Compare Web site, which is designed to ...
... awareness campaign with ... ,Better Fats Sisters, DALLAS, May ... (monounsaturated and polyunsaturated) can help reduce,their risk of heart disease, according ... view the Multimedia News Release, go to:, http://www.prnewswire.com/mnr/aha/33320/ "Heart ...
... Name to Create Brand Platform, Launches New ... Website, Readies for Market Entry, ... in therapeutic warming and non-pharmacologic pain management,systems, announced today that ... is expanding its line of patented therapeutic warming,systems which reduce ...
... Georgacas and Mark ... Mishek as its newest members, ... Board of Directors of ClearWay Minnesota(SM) approved $1.4 million in,new ... to reduce exposure to secondhand smoke by advancing smoke-free,policy efforts ...
... new ... agreements, ... leading distributor of at-home testing diagnostics,for the chronically ill, life-saving prescription ... reported,financial results for the first quarter period-ended March 31, 2008. Recent,highlights ...
... Systems, Inc. played,host to nearly 300 guests at ... prominent speaker who provided a poignant report on ... ), David R. Brousell, Editor-in-Chief of ... at the JW Marriott in Downtown Grand,Rapids. His ...
Cached Medicine News:Health News:U.S. Web Site Helps Consumers Compare Hospitals 2Health News:Video: Most Americans Don't Know 'Better Fats' Benefit Heart Health 2Health News:Video: Most Americans Don't Know 'Better Fats' Benefit Heart Health 3Health News:Coventina Healthcare Enterprises, Inc. is Now ReGear Life Sciences, Inc. 2Health News:ClearWay Minnesota(SM) Board Approves $1.4 Million in New Grants to Reduce Tobacco's Harm 2Health News:ClearWay Minnesota(SM) Board Approves $1.4 Million in New Grants to Reduce Tobacco's Harm 3Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 2Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 3Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 4Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 5Health News:PowerPlex 2008 User Conference Features Manufacturing Survey by Leading Publication Managing Automation 2Health News:PowerPlex 2008 User Conference Features Manufacturing Survey by Leading Publication Managing Automation 3
Transcranil vascular DWL doppler....
... 9100HS is a powerful automated system capable ... Choose from 6 user-programmable test protocols to ... exam. Any tests not included in the ... be handled using the Doppler, PVR and ...
The CD Horizon M10 Spinal System provide spine surgeons comprehensive solutions for the treatment of spinal deformities, trauma reconstruction, and degenerative conditions....
Silhouette is easy to use with uncompromised biomechanics and is the most refined posterior fixation system....
Medicine Products: